Logo.jpg
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
October 23, 2024 08:30 ET | NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
July 30, 2021 - ROSEN LOGO.jpg
NRXP DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages NRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important March 21 Deadline in Securities Class Action – NRXP, NRXPW
March 21, 2022 10:57 ET | The Rosen Law Firm PA
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP, NRXPW) between...
DEADLINE ALERT for VWAGY, NRXP, BMBL, CLVT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
March 14, 2022 11:00 ET | Law Offices of Howard G. Smith
BENSALEM, Pa., March 14, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NRx Pharmaceuticals, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important March 21 Deadline in Securities Class Action – NRXP, NRXPW
March 13, 2022 15:04 ET | The Rosen Law Firm PA
NEW YORK, March 13, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP, NRXPW) between...
GPM Logo.jpg
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NRx Pharmaceuticals, Inc. (NRXP)
March 11, 2022 14:00 ET | Glancy Prongay & Murray LLP
LOS ANGELES, March 11, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 21, 2022 deadline to file a lead plaintiff motion in the class action...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A TOP RANKED LAW FIRM, Encourages NRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NRXP, NRXPW
March 08, 2022 17:49 ET | The Rosen Law Firm PA
NEW YORK, March 08, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP, NRXPW) between...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for OSH, FCFS, VWAGY, and NRXP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 08, 2022 12:00 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, March 08, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for VWAGY, NRXP, BMBL, CLVT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
March 07, 2022 11:00 ET | Law Offices of Howard G. Smith
BENSALEM, Pa., March 07, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
GPM Logo.jpg
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NRx Pharmaceuticals, Inc. (NRXP)
March 01, 2022 12:00 ET | Glancy Prongay & Murray LLP
LOS ANGELES, March 01, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 21, 2022 deadline to file a lead plaintiff motion in the class action...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for OSH, FCFS, VWAGY, and NRXP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
February 28, 2022 11:00 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...